[EN] SERINE/THREONINE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE SÉRINE/THRÉONINE KINASES
申请人:ARRAY BIOPHARMA INC
公开号:WO2015103137A1
公开(公告)日:2015-07-09
Compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof are provided, which are useful for the treatment of diseases. Methods of using compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such diseases, or associated pathological conditions are disclosed.
Scandium(III) or lanthanide(III) triflates as recyclable catalysts for the direct acetylation of alcohols with acetic acid
作者:Anthony G. M. Barrett、D. Christopher Braddock
DOI:10.1039/a606484a
日期:——
Scandium(III) or lanthanide(III) triflates are
found to efficiently catalyse the direct acetylation of primary, secondary
or tertiary alcohols with acetic acid; the catalyst can be recovered
quantitatively and re-used with no loss of activity.
Electrochemical fluorination of several esters derived from oxolane-2-yl-carboxylic acid, oxolane-2-yl-methanol and oxane-2-yl-methanol
作者:Takashi Abe、Masanori Tamura、Akira Sekiya
DOI:10.1016/j.jfluchem.2004.11.014
日期:2005.3
Electrochemical fluorination (ECF) of the ester derivatives of oxolane-2-yl-carboxylic acid (1), oxolane-2-yl-methanol (2) and oxane-2-yl-methanol (3) were investigated. Perfluoro(oxolane-2-yl-carbonylfluoride) (4) was obtained from derivatives of 1 and 2, and perfluoro(oxane-2-yl-carbonylfluoride) (5) was obtained from derivatives of 3 as the desired compounds, respectively. From the ECF of acetates
[EN] QUINAZOLINE COMPOUNDS AS SERINE/THREONINE KINASE INHIBITORS<br/>[FR] COMPOSÉS DE QUINAZOLINE UTILES EN TANT QU'INHIBITEURS DE LA SÉRINE/THRÉONINE KINASE
申请人:ARRAY BIOPHARMA INC
公开号:WO2013020062A1
公开(公告)日:2013-02-07
Compounds having the formula (I) wherein R1, R2, R3 and Ar as defined herein are inhibitors of ERK kinase. Also disclosed are compositions and methods for treating hyperproliferative disorders.
QUINAZOLINE COMPOUNDS AS SERINE/THREONINE KINASE INHIBITORS
申请人:Blake James F.
公开号:US20150087664A1
公开(公告)日:2015-03-26
Compounds having the formula (I) wherein R
1
, R
2
, R
3
and Ar as defined herein are inhibitors of ERK kinase. Also disclosed are compositions and methods for treating hyperproliferative disorders.